Illinois Gov. JB Pritzker told the Chicago Sun-Times he lost 80 pounds since spring 2024 using a GLP-1 medication after being diagnosed with prediabetes and later Type 2 diabetes, and that he stopped taking insulin nine months ago. The interview, part of a broader explainer on GLP-1 drugs, notes that Illinois Medicaid covers GLP-1s only for a Type 2 diabetes diagnosis, not for weight loss alone, unlike the state's employee health plan, which expanded coverage in 2023 to include weight-loss use at a cost of $147 million in fiscal year 2025. The piece also covers FDA eligibility criteria, insurance coverage patterns, out-of-pocket pricing, and health risks including misuse of unapproved compounded versions. Pritzker's disclosure comes as he is seen as a potential 2028 presidential contender, though he says his focus is on reelection as governor this November.
Why it mattersThe gap between Illinois' generous state-employee GLP-1 coverage and its diabetes-only Medicaid policy underscores the budget pressure states face as they weigh whether to extend obesity coverage to Medicaid enrollees.